Modeling gene-by-environment interaction in comorbid depression with alcohol use disorders via an integrated bioinformatics approach

BackgroundComorbidity of Major Depressive Disorder (depression) and Alcohol Use Disorders (AUD) is well documented. Depression, AUD, and the comorbidity of depression with AUD show evidence of genetic and environmental influences on susceptibility. We used an integrated bioinformatics approach, mining available data in multiple databases, to develop and refine a model of gene-by-environment interaction consistent with this comorbidity.MethodsWe established the validity of a genetic model via queries against NCBI databases, identifying and validating TNF (Tumor Necrosis Factor) and MTHFR (Methylenetetrahydrofolate Reductase) as candidate genes. We used the PDG-ACE algorithm (Prioritizing Disease Genes by Analysis of Common Elements) to show that TNF and MTHFR share significant commonality and that this commonality is consistent with a response to environmental exposure to ethanol. Finally, we used MetaCore from GeneGo, Inc. to model a gene-by-environment interaction consistent with the data.ResultsTNF Alpha Converting Enzyme (TACE) activity is suppressed by ethanol exposure, resulting in reduced TNF signaling. TNF binds to TNF receptors, initiating signal transduction pathways that activate MTHFR expression. MTHFR is an essential enzyme in folate metabolism and reduced folate levels are associated with both AUD and depression. Integrating these pieces of information our model shows how excessive alcohol use would be expected to lead to reduced TNF signaling, reduced MTHFR expression, and increased susceptibility to depression.ConclusionThe proposed model provides a novel hypothesis on the genetic etiology of comorbid depression with AUD, consistent with established clinical and biochemical data. This analysis also provides an example of how an integrated bioinformatics approach can maximize the use of available biomedical data to improve our understanding of complex disease.

[1]  M. Camilleri Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2]  G. Natoli,et al.  Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. , 1998, Biochemical pharmacology.

[3]  R. Rozen,et al.  Regulatory studies of murine methylenetetrahydrofolate reductase reveal two major promoters and NF-kappaB sensitivity. , 2005, Biochimica et biophysica acta.

[4]  D. Mrazek,et al.  Cytochrome P450 2D6 genotype variation and venlafaxine dosage. , 2007, Mayo Clinic proceedings.

[5]  Simon Gilbody,et al.  Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. , 2006, American journal of epidemiology.

[6]  B. Garvik,et al.  Principles for the Buffering of Genetic Variation , 2001, Science.

[7]  A. Coppen,et al.  Serum and red blood cell folate in depression , 1989, Acta psychiatrica Scandinavica.

[8]  F. Goodwin Manic-Depressive Illness , 1990 .

[9]  Eric Boerwinkle,et al.  Determinants of the success of whole-genome association testing. , 2005, Genome research.

[10]  J. Kolls,et al.  Alcohol reversibly disrupts TNF-α/TACE interactions in the cell membrane , 2005, Respiratory research.

[11]  D. Mrazek,et al.  The impact of CYP allelic variation on antidepressant metabolism: a review , 2007, Expert opinion on drug metabolism & toxicology.

[12]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[13]  A. Coppen,et al.  The biology of folate in depression: implications for nutritional hypotheses of the psychoses. , 1986, Journal of psychiatric research.

[14]  T. Nikolskaya,et al.  Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[15]  D. Lawlor,et al.  The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis , 2006, Molecular Psychiatry.

[16]  R. Pomerantz,et al.  Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. , 2002, Virology.

[17]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[18]  A. Coppen,et al.  Depression and tetrahydrobiopterin: the folate connection. , 1989, Journal of affective disorders.

[19]  S. Manna,et al.  Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression. , 1998, Archives of biochemistry and biophysics.

[20]  P. Rieckmann,et al.  Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. , 2002, Psychoneuroendocrinology.

[21]  M. Birrer,et al.  TNF-α Gene Expression in Macrophages: Regulation by NF-κB Is Independent of c-Jun or C/EBPβ1 , 2000, The Journal of Immunology.

[22]  Lon R Cardon,et al.  Prospects and pitfalls in whole genome association studies , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[23]  K. Kendler,et al.  Sex-specific genetic influences on the comorbidity of alcoholism and major depression in a population-based sample of US twins. , 2000, Archives of general psychiatry.

[24]  C. Carlson,et al.  Mapping complex disease loci in whole-genome association studies , 2004, Nature.

[25]  Sang-Woon Choi,et al.  Effects of alcohol on folate metabolism: implications for carcinogenesis. , 2005, Alcohol.

[26]  R. Newcombe,et al.  Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. , 2003, Clinical chemistry.

[27]  Sean Ekins,et al.  Pathway mapping tools for analysis of high content data. , 2007, Methods in molecular biology.

[28]  P. R. Boyd,et al.  Whole genome linkage scan of recurrent depressive disorder from the depression network study. , 2005, Human molecular genetics.

[29]  O. Demirhan,et al.  Cytogenetic effects of ethanol on chronic alcohol users. , 2008, Alcohol and alcoholism.

[30]  P. Rieckmann,et al.  Expression of tumor necrosis factor-α and interferon-γ mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis , 2002, Psychoneuroendocrinology.

[31]  P E Shrout,et al.  Socioeconomic status and psychiatric disorders: the causation-selection issue. , 1992, Science.

[32]  M C Neale,et al.  Alcoholism and major depression in women. A twin study of the causes of comorbidity. , 1993, Archives of general psychiatry.

[33]  Y. Teo,et al.  Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders , 2004, Psychiatric genetics.

[34]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[35]  A. Coppen,et al.  Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. , 2000, Journal of affective disorders.

[36]  S. Manna,et al.  Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-κB, degradation of IκBα, nuclear translocation of p65, and subsequent gene expression , 1998 .

[37]  A. Coppen,et al.  Treatment of depression: time to consider folic acid and vitamin B12 , 2005, Journal of psychopharmacology.

[38]  Richard C. McEachin,et al.  Identifying hypothetical genetic influences on complex disease phenotypes , 2009, BMC Bioinformatics.

[39]  A. Coppen,et al.  Plasma Folate and Affective Morbidity During Long-Term Lithium Therapy , 1982, British Journal of Psychiatry.

[40]  P. Scheurich,et al.  Tumor Necrosis Factor Receptor-associated Factor (TRAF) 1 Regulates CD40-induced TRAF2-mediated NF-κB Activation* , 2004, Journal of Biological Chemistry.

[41]  M. Lynskey The comorbidity of alcohol dependence and affective disorders: treatment implications. , 1998, Drug and alcohol dependence.

[42]  M. Abou-Saleh,et al.  Folic acid and the treatment of depression. , 2006, Journal of psychosomatic research.

[43]  A. Coppen,et al.  Folic acid enhances lithium prophylaxis. , 1986, Journal of affective disorders.

[44]  N. el-Guebaly,et al.  Sociodemographic Factors Associated with Comorbid Major Depressive Episodes and Alcohol Dependence in the General Population , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[45]  D. Mischoulon,et al.  The role of folate in depression and dementia. , 2007, The Journal of clinical psychiatry.

[46]  P. Scheurich,et al.  Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. , 2004, The Journal of biological chemistry.

[47]  T. Tatusova,et al.  Entrez Gene: gene-centered information at NCBI , 2006, Nucleic Acids Res..

[48]  Mann-Jy Chen,et al.  Mapping the Domain(s) Critical for the Binding of Human Tumor Necrosis Factor-α to Its Two Receptors (*) , 1995, The Journal of Biological Chemistry.

[49]  Christopher G. Davis,et al.  The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: A family history study , 1997, British Journal of Psychiatry.

[50]  M. Folstein,et al.  The homocysteine hypothesis of depression. , 2007, The American journal of psychiatry.

[51]  M. Birrer,et al.  TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta. , 2000, Journal of immunology.

[52]  Joy L. Lee,et al.  Cytochrome P450 testing for better psychiatric care. , 2007, Journal of psychosocial nursing and mental health services.

[53]  B. Henderson,et al.  The MTHFR C677T Polymorphism and Colorectal Cancer: The Multiethnic Cohort Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[54]  D. Hasin,et al.  Depressive symptoms and DSM-III-R alcohol dependence: general population results. , 1993, Addiction.